Gut hormone-based diabetes drugs may also boost weight loss by curbing cravings

By: | Published: June 10, 2015 5:36 PM

Researchers have revealed that a class of gut hormone-based diabetes drugs may also aid weight loss by curbing cravings.

Researchers have revealed that a class of gut hormone-based diabetes drugs may also aid weight loss by curbing cravings.

This study provided evidence that GLP-1 receptor agonists alter the brain’s response to food, possibly reducing cravings and increasing satisfaction while eating.

Previous studies have shown that the brains of obese people have a greater response to pictures of food than those of lean people, and a reduced reward response during the consumption of food, which may lead to overeating.

Researchers in Amsterdam tested the hypothesis that the GLP-1 receptor agonist exenatide, a medication which mimics the effects of natural GLP-1 by binding to the GLP-1 receptor, was helping patients with type 2 diabetes lose weight by altering the brain’s response to food consumption and decreasing appetite.

Get live Stock Prices from BSE and NSE and latest NAV, portfolio of Mutual Funds, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Switch to Hindi Edition